Lehrer Steven, Rheinstein Peter H
Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, U.S.A.
Severn Health Solutions, Severna Park, MD, U.S.A.
In Vivo. 2018 Nov-Dec;32(6):1485-1489. doi: 10.21873/invivo.11404.
BACKGROUND/AIM: Polio is predominantly an enteric viral infection that was progressively eradicated in the United States after the introduction of polio vaccine in the early 1950s. U.S. colorectal cancer rates have dropped steadily for individuals born between 1890 and 1950, but have been increasing for every generation born since 1950. Moreover, the lowest worldwide age adjusted rates of colorectal cancer in 2012 were in sub-Saharan Africa, Gambia and Mozambique, where polio has not been eradicated. In the current study, poliomyelitis incidence in US states before the introduction of polio vaccine was analyzed.
Reported cases of poliomyelitis per 100,000 population by state 1932-1951 were from Centers for Disease Control. Colorectal cancer deaths per 100,000 in men (2005-2009) by US State are from the American Cancer Society. US state overweight and obesity data are from the Centers for Disease Control and Prevention (CDC). Smoking data are from the CDC.
By US state, colorectal cancer incidence per 100,000 in men for 2005-2009 was inversely correlated with reported cases of poliomyelitis per 100,000 for 1932-1951 (r=-0.311, p=0.032). Colorectal cancer deaths per 100,000 in men in 2005-2009 were also inversely correlated with reported cases of poliomyelitis per 100,000 by state for 1932-1951 (r=-0.493, p<0.001). The relationship between colorectal cancer deaths and polio incidence was significant (β=-0.196, p=0.028) and independent of the effects of smoking (β=0.289, p=0.012) and overweight (β=0.547, p<0.001). The relationship in females with colorectal cancer was identical.
Polio virus infection of cells of the colon may induce some degree of resistance to the development of colon cancer decades later. The effect of polio virus infection seems to be especially potent in reducing the rate of death from colon cancer.
背景/目的:脊髓灰质炎主要是一种肠道病毒感染,在20世纪50年代初引入脊髓灰质炎疫苗后,美国的脊髓灰质炎逐渐被根除。1890年至1950年出生的美国人结肠癌发病率稳步下降,但自1950年以来每一代出生的人的发病率都在上升。此外,2012年全球年龄标准化结肠癌发病率最低的地区是撒哈拉以南非洲的冈比亚和莫桑比克,这些地区的脊髓灰质炎尚未根除。在本研究中,分析了美国各州在引入脊髓灰质炎疫苗之前的脊髓灰质炎发病率。
1932年至1951年各州每10万人中脊髓灰质炎报告病例数来自疾病控制中心。美国各州2005 - 2009年男性每10万人中的结肠癌死亡人数来自美国癌症协会。美国各州超重和肥胖数据来自疾病控制与预防中心(CDC)。吸烟数据来自CDC。
按美国各州计算,2005 - 2009年男性每10万人中的结肠癌发病率与1932 - 1951年每10万人中的脊髓灰质炎报告病例数呈负相关(r = -0.311,p = 0.032)。2005 - 2009年男性每10万人中的结肠癌死亡人数也与1932 - 1951年各州每10万人中的脊髓灰质炎报告病例数呈负相关(r = -0.493,p < 0.001)。结肠癌死亡与脊髓灰质炎发病率之间的关系显著(β = -0.196,p = 0.028),且独立于吸烟(β = 0.289,p = 0.012)和超重(β = 0.547,p < 0.001)的影响。女性结肠癌患者中的关系相同。
结肠细胞的脊髓灰质炎病毒感染可能在数十年后诱导对结肠癌发生的某种程度的抗性。脊髓灰质炎病毒感染的影响似乎在降低结肠癌死亡率方面尤为显著。